Log In
BCIQ
Print this Print this
 

BenzaClin

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionClindamycin 1% plus benzoyl peroxide 5% topical gel
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationAcne
Indication DetailsTreat acne
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$422.5M

$422.5M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/18/2011

$422.5M

$422.5M

0

Get a free BioCentury trial today